These small studies do not provide conclusive evidence that C282Y HFE is a highly significant disease modifier, but the increased prevalence of AD in those who also carry TF C2, which is associated with increased redox-active iron levels, suggests that increased iron is a likely risk factor for AD.
1
—
—